Home › Funds › DEERFIELD MANAGEMENT COMPANY, L.P. › ZBIO

DEERFIELD MANAGEMENT COMPANY, L.P. position in ZBIO

ZENAS BIOPHARMA INC COM · Health Care

DEERFIELD MANAGEMENT COMPANY, L.P. reported holding 67,200,000 shares of ZBIO (ZENAS BIOPHARMA INC COM) in its Q2 2026 13F filing — a position valued at US$80.3M, representing 1.01% of its reported portfolio and ranking #30 among its reported holdings. DEERFIELD MANAGEMENT COMPANY, L.P. has disclosed ZBIO holdings in 7 of the last 8 reported quarters, going back to Q3 2024.

Latest position (Q2 2026)67.20M sh
Reported value held$80.32M
Portfolio Weight1.01%
First reportedQ3 2024
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How DEERFIELD MANAGEMENT COMPANY, L.P.'s ZBIO position evolved

DEERFIELD MANAGEMENT COMPANY, L.P. first disclosed a stake in ZBIO in Q3 2024 at 1,562,942 shares (US$26.4M). The position peaked in Q2 2026 at 67,200,000 shares, worth US$80.3M. Across 7 filings, DEERFIELD MANAGEMENT COMPANY, L.P. increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 4 time(s). The most recent filing (Q2 2026) shows 67,200,000 shares valued at US$80.3M — an increase of 2,200,000 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2024 1.56M $26.44M New
Q4 2024 1.56M $12.80M Hold
Q1 2025 1.56M $12.35M Hold
Q2 2025 1.56M $15.14M Hold
Q3 2025 1.56M $34.70M Hold
Q1 2026 65.00M $67.25M New
Q2 2026 67.20M $80.32M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ZBIO and 13F data

ZBIO (ZENAS BIOPHARMA INC COM) is a Health Care company. 68 other funds we track also report a position in ZBIO — the largest reported positions include SR ONE CAPITAL MANAGEMENT, LP (US$127.9M), NEA Management Company, LLC (US$102.1M), Enavate Sciences GP, LLC (US$99.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ZBIO

All ZBIO fund holders →

FAQ

How long has DEERFIELD MANAGEMENT COMPANY, L.P. held ZBIO?

DEERFIELD MANAGEMENT COMPANY, L.P. has disclosed ZBIO holdings in 7 of the last 8 reported quarters, going back to Q3 2024.

What is DEERFIELD MANAGEMENT COMPANY, L.P.'s current position in ZBIO?

As of Q2 2026, DEERFIELD MANAGEMENT COMPANY, L.P. holds 67.20M shares of ZBIO (ZENAS BIOPHARMA INC COM), valued at $80.32M, representing 1.01% of its reported portfolio and ranking #30.

Has DEERFIELD MANAGEMENT COMPANY, L.P. been buying or selling ZBIO?

In the latest 13F filing (Q2 2026), DEERFIELD MANAGEMENT COMPANY, L.P. increased its position in ZBIO. The position peaked in Q2 2026 at 67.20M shares.

Which other funds hold ZBIO?

Other major institutional holders of ZBIO include SR ONE CAPITAL MANAGEMENT, LP, NEA Management Company, LLC, Enavate Sciences GP, LLC, among 68 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.